مرک و مدرنا داده های امیدوارکننده ای را در مورد آزمایش واکسن سرطان منتشر کردند

Merck and Moderna release promising data on cancer vaccine trial

A study of a personalized vaccine combined with an existing immunotherapy found the treatment helped patients with melanoma avoid cancer recurrence. The combination trains the patient's immune system to go after cancer cells.